Xcout Intel
Kerecis hf
Kerecis hf. is an Iceland-based biologic wound care company headquartered in Reykjavik, specializing in innovative medical products derived from fish skin to treat tissue damage.
Subscribe to see Kerecis hf’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kerecis hf at a glance
Kerecis hf is a company headquartered in Iceland. It has raised at least $7.6M across the 5 funding rounds on record. Its most recent funding round raised $1.8M in August 2022. Xcout tracks 8 named people at Kerecis hf, including G. Fertram Sigurjonsson (Founder).
Kerecis hf leadership
- G. Fertram SigurjonssonFounder
- Joe SmithExecutive Vice President Research & Product Life Cycle Management
- Gunnar Johannsson, MDSenior Vice President & Medical Director, Co-Head Clinical Development
- Bernd Greiner, MDVice President Region Europe
- Christopher HarteVice President International Markets
- Gudmundur OskarssonVice President Product & Medical
2 more named people on record for Kerecis hf, with roles, board committees and tenure — see the full roster →
Kerecis hf funding rounds
At least $7.6M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.8M | — | |
| SEC Form D filing | $109,567 | — | |
| SEC Form D filing | $4.1M | — | |
| SEC Form D filing | $1.5M | — | |
| SEC Form D filing | $111,582 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Kerecis hf competitors
A few of Kerecis hf's closest competitors — see the full list of competitors and alternatives →
Nexsis Biosciences LLC distributes advanced tissue-repair products and biomaterials derived from porcine small intestinal submucosa (SIS) for surgical and wound management applications. The company serves healthcare providers and patients by offering extracellular matrix (ECM) devices that support site-specific tissue remodeling and healing without leaving permanent material behind.
Össur hf. is a company based in Iceland that develops, manufactures and sells non-invasive equipment for orthopaedics, including bracing and support products, compression therapy, and prosthetics. The company is headquartered in Reykjavík, with offices in the Americas, Europe, and Asia, and distributors in other markets.
CollPlant Biotechnologies Ltd. is a biotechnology company headquartered in Rehovot, Israel. The company focuses on regenerative medicine and reports its financial results in U.S. dollars.
PolyNovo Limited develops and manufactures synthetic skin substitutes using its proprietary NovoSorb technology. The company provides medical products designed to support wound management and natural healing for healthcare professionals and patients.
Humabiologics, Inc. is a regenerative medicine company that provides human-derived biomaterials such as collagen and gelatin for research and therapeutic applications.
Nanordica Medical is an Estonian medtech company founded in 2019 and headquartered in Tallinn, dedicated to developing first-in-class wound care products based on nanotechnology.
Get Kerecis hf's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Kerecis hf? Suggest a correction · Work at Kerecis hf? Claim this profile
Is this your company? Add the Xcout Intel badge to your website
Free, for any company on Xcout Intel. It links visitors to this profile.
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Kerecis hf in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access